Another bit of information I found on the Crispr Therapeutics Car-T trial:
"Three patients developed moderate cytokine release syndrome, an immune-based side effect often associated with CAR-T therapy."
Im just speculating here but I find it interesting since Humanigen stated they are not locked into just collaborating with Kite on this. Crispr is one of the most hyped up Biotech companies right now and a collaboration with them would be very validating. They are also collaborating with Vertex already who has billions in cash at their disposal
News 
Market Data 
Discover 
AI
